telmisartan has been researched along with Chronic Kidney Diseases in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 11 (73.33) | 24.3611 |
| 2020's | 3 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gill, A; Jarolimek, W; Pollock, C; Saad, S; Schilter, H; Stangenberg, S; Wong, MG; Wong, MY; Zaky, A | 1 |
| Akabane, R; Miyagawa, Y; Miyakawa, H; Nagakawa, M; Ogawa, M; Sakatani, A; Takemura, N | 1 |
| Cai, Y; Chang, D; Ju, S; Lu, CQ; Min, SD; Wang, YC; Xu, TT; Zhang, SJ; Zhao, Z | 1 |
| Chang, A; Kramer, H | 1 |
| Clase, CM; Dehghan, M; Dunkler, D; Gao, P; Heinze, G; Kohl, M; Mann, JF; Oberbauer, R; Teo, KK; Yusuf, S | 1 |
| Sharma, K; Sweiss, N | 1 |
| Izumikawa, Y; Kato, H; Kojima, K; Kubo, E; Nagura, M; Nosaka, H; Shima, T; Shimada, M; Shiraishi, T; Tanemoto, M; Tomioka, S; Uchida, S; Ueda, S; Yano, H | 1 |
| Abebe, KZ; Braun, WE; Brosnahan, G; Chapman, AB; Czarnecki, PG; Flessner, MF; Grantham, JJ; Harris, PC; Hogan, MC; Miskulin, DC; Moore, CG; Perrone, RD; Rahbari-Oskoui, FF; Schrier, RW; Steinman, TI; Torres, VE; Winklhofer, FT | 1 |
| Adachi, M; Hayata, M; Hirata, S; Kadowaki, D; Kakizoe, Y; Kitamura, K; Miyasato, Y; Miyoshi, T; Mizumoto, T; Morinaga, J; Mukoyama, M; Nakagawa, T; Narita, Y; Sakai, Y; Uchimura, K; Ueda, M | 1 |
| Alter, M; Ando, R; Antonenko, V; Chaykovska, L; Hasan, AA; Hocher, B; Klein, T; Okuda, S; Rahnenführer, J; Reichetzeder, C; Sharkovska, Y; Tammen, H; Tsuprykov, O; Ueda, S; von Websky, K; Yamagishi, SI | 1 |
| Arru, D; Assaretti, S; Baralla, A; Carru, C; Ena, S; Mangoni, AA; Satta, AE; Sotgia, S; Sotgiu, E; Zinellu, A | 1 |
| He, LQ; Ni, ZH; Peng, W; Wang, NS; Wang, Y; Yu, KN; Zhang, CM | 1 |
| Knap, N; Larczynski, W; Neuwelt, A; Petranyuk, A; Renke, M; Rutkowski, B; Rutkowski, P; Tylicki, L; Wozniak, M | 1 |
| Abe, M; Maruyama, T; Matsumoto, K; Matsumoto, S; Okada, K | 1 |
| Bednarski, R; Donderski, R; Heleniak, Z; Lizakowski, S; Manitius, J; Przybylska, M; Renke, M; Rutkowski, B; Rutkowski, P; Sulikowska, B; Tylicki, L | 1 |
1 review(s) available for telmisartan and Chronic Kidney Diseases
| Article | Year |
|---|---|
Adiponectin effects on the kidney.
Topics: Adiponectin; Albuminuria; Amlodipine; AMP-Activated Protein Kinases; Animals; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disease Progression; Humans; Kidney; Kidney Diseases; Mice; Obesity; Oxidative Stress; Perindopril; Renal Insufficiency, Chronic; Telmisartan | 2014 |
7 trial(s) available for telmisartan and Chronic Kidney Diseases
| Article | Year |
|---|---|
Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 2; Diet; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Feeding Behavior; Female; Follow-Up Studies; Global Health; Glomerular Filtration Rate; Humans; Incidence; Male; Middle Aged; Prospective Studies; Ramipril; Renal Insufficiency, Chronic; Risk Factors; Telmisartan; Time Factors | 2013 |
Angiotensin blockade in late autosomal dominant polycystic kidney disease.
Topics: Adolescent; Adult; Albuminuria; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney Failure, Chronic; Lisinopril; Male; Middle Aged; Polycystic Kidney, Autosomal Dominant; Renal Insufficiency, Chronic; Telmisartan; Young Adult | 2014 |
Effects of Ramipril and Telmisartan on Plasma Concentrations of Low Molecular Weight and Protein Thiols and Carotid Intima Media Thickness in Patients with Chronic Kidney Disease.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Carotid Arteries; Cysteine; Drug Combinations; Female; Homocysteine; Humans; Male; Middle Aged; Ramipril; Renal Insufficiency, Chronic; Telmisartan; Tunica Intima | 2016 |
A Clinical Multicenter Randomized Controlled Study on JianpiQinghua Decoction in Treating Stage 3 Chronic Kidney Disease with A Syndrome Type of Dampness-heat due to Spleen Deficiency.
Topics: Benzimidazoles; Benzoates; Double-Blind Method; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; Phytotherapy; Prospective Studies; Quality of Life; Renal Insufficiency, Chronic; Telmisartan | 2016 |
High-dose angiotensin-converting enzyme inhibitor attenuates oxidative stress in patients with chronic kidney disease.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cilazapril; Cross-Over Studies; Dinoprost; Drug Therapy, Combination; Female; Humans; Isoprostanes; Male; Oxidative Stress; Renal Insufficiency, Chronic; Renin-Angiotensin System; Telmisartan | 2009 |
Blood pressure-lowering and antiproteinuric effect of switching from high-dose angiotensin receptor blockers to normal-dose telmisartan and low-dose hydrochlorothiazide in hypertensive patients with chronic kidney disease.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Pressure; Dose-Response Relationship, Drug; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Proteinuria; Renal Insufficiency, Chronic; Telmisartan | 2010 |
The enhanced renin-angiotensin-aldosteron system pharmacological blockade--which is the best?.
Topics: Adult; Albuminuria; Amides; Angiotensin Receptor Antagonists; Benzimidazoles; Benzoates; Comorbidity; Cross-Over Studies; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Eplerenone; Female; Fumarates; Humans; Hypertension; Male; Mineralocorticoid Receptor Antagonists; Prospective Studies; Proteinuria; Renal Insufficiency, Chronic; Renin; Renin-Angiotensin System; Severity of Illness Index; Spironolactone; Telmisartan; Treatment Outcome | 2012 |
7 other study(ies) available for telmisartan and Chronic Kidney Diseases
| Article | Year |
|---|---|
Semicarbazide-sensitive amine oxidase inhibition ameliorates albuminuria and glomerulosclerosis but does not improve tubulointerstitial fibrosis in diabetic nephropathy.
Topics: Albuminuria; Allylamine; Amine Oxidase (Copper-Containing); Animals; Benzamides; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Inhibitors; Fibronectins; Fibrosis; Kidney Glomerulus; Kidney Tubules; Leukocyte Common Antigens; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Renal Insufficiency, Chronic; Telmisartan | 2020 |
Effects of telmisartan on proteinuria and systolic blood pressure in dogs with chronic kidney disease.
Topics: Animals; Blood Pressure; Dog Diseases; Dogs; Female; Male; Proteinuria; Renal Insufficiency, Chronic; Retrospective Studies; Telmisartan; Treatment Outcome | 2020 |
Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Cardio-Renal Syndrome; Diastole; Disease Models, Animal; Echocardiography; Fibrosis; Heart Failure; Hypertrophy, Left Ventricular; Male; Natriuretic Peptide, Brain; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Stroke Volume; Telmisartan; Ventricular Function, Left; Ventricular Remodeling | 2021 |
Moving dietary management of diabetes forward.
Topics: Benzimidazoles; Benzoates; Diabetes Mellitus, Type 2; Diet; Feeding Behavior; Female; Humans; Male; Ramipril; Renal Insufficiency, Chronic; Telmisartan | 2013 |
Blood pressure control and satisfaction of hypertensive patients following a switch to combined drugs of an angiotensin receptor blocker and a calcium channel blocker in clinical practice of nephrology.
Topics: Aged; Amlodipine; Angiotensin Receptor Antagonists; Azetidinecarboxylic Acid; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Drug Combinations; Drug Costs; Drug Substitution; Female; Humans; Hypertension; Imidazoles; Male; Medication Adherence; Middle Aged; Nephrology; Patient Satisfaction; Practice Patterns, Physicians'; Renal Insufficiency, Chronic; Retrospective Studies; Surveys and Questionnaires; Telmisartan; Tetrazoles; Valsartan | 2015 |
Combination therapy with renin-angiotensin-aldosterone system inhibitor telmisartan and serine protease inhibitor camostat mesilate provides further renoprotection in a rat chronic kidney disease model.
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Creatinine; Disease Models, Animal; Drug Therapy, Combination; Esters; Fibrosis; Gabexate; Guanidines; Kidney; Male; Oxidative Stress; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Renin; Renin-Angiotensin System; Serine Proteinase Inhibitors; Telmisartan | 2016 |
The dipeptidyl peptidase inhibitor linagliptin and the angiotensin II receptor blocker telmisartan show renal benefit by different pathways in rats with 5/6 nephrectomy.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biomarkers; Blood Pressure; Chromatography, Liquid; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Fibrosis; Kidney; Linagliptin; Male; Mass Spectrometry; Nephrectomy; Rats, Inbred F344; Rats, Sprague-Dawley; Rats, Transgenic; Renal Insufficiency, Chronic; Renin-Angiotensin System; Signal Transduction; Telmisartan; Time Factors | 2016 |